Dysis View
Payments companies reported to CMS as associated with Dysis View. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Dysis View, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Dysis View
These are the largest totals companies reported as associated with Dysis View. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Diana Herrera | Houston, TX | Obstetrics & Gynecology | $132.93 |
| Sanaz Amini | Loma Linda, CA | Obstetrics & Gynecology | $124.28 |
| Alireza Abidi | Sacramento, CA | Gynecologic Oncology | $124.28 |
| Deborah Arden | Boston, MA | $124.28 | |
| Alia Shbeeb | Riverside, CA | Obstetrics & Gynecology | $124.28 |
| Scott Lentz | Los Angeles, CA | Gynecologic Oncology | $124.27 |
| Sabah Langston | Riverside, CA | Obstetrics & Gynecology | $124.27 |
| Mehdi Moslemi-Kebria | Upland, CA | Gynecologic Oncology | $124.27 |
| Janet Zhang | Riverside, CA | Obstetrics & Gynecology | $124.27 |
| Jennifer Chou-Kim | Riverside, CA | Obstetrics & Gynecology | $124.27 |
Prescribed Dysis View?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.